IL-1R–MyD88 signaling in keratinocyte transformation and carcinogenesis

Keratinocyte MyD88 is a component of an IL-1α–IL-1R autocrine loop that drives Ras-mediated transformation in vitro and contributes to skin tumor formation in vivo.

[1]  H. Dinh,et al.  IL-36R ligands are potent regulators of dendritic and T cells. , 2011, Blood.

[2]  D. Bar-Sagi,et al.  RAS oncogenes: weaving a tumorigenic web , 2011, Nature Reviews Cancer.

[3]  Joseph M. Connors,et al.  Oncogenically active MYD88 mutations in human lymphoma , 2011, Nature.

[4]  F. Watt,et al.  Tumor formation initiated by nondividing epidermal cells via an inflammatory infiltrate , 2010, Proceedings of the National Academy of Sciences.

[5]  P. Hainaut,et al.  Dual function of MyD88 in RAS signaling and inflammation, leading to mouse and human cell transformation. , 2010, The Journal of clinical investigation.

[6]  M. Bianchi,et al.  TLR4‐mediated skin carcinogenesis is dependent on immune and radioresistant cells , 2010, The EMBO journal.

[7]  J. Rundhaug,et al.  Molecular Mechanisms of Mouse Skin Tumor Promotion , 2010, Cancers.

[8]  L. Pusztai,et al.  Inhibition of lipocalin 2 impairs breast tumorigenesis and metastasis. , 2009, Cancer research.

[9]  C. Counter,et al.  ELR+ CXC chemokines and oncogenic Ras-mediated tumorigenesis. , 2009, Carcinogenesis.

[10]  J. Mauer,et al.  MyD88 signaling in the CNS is required for development of fatty acid-induced leptin resistance and diet-induced obesity. , 2009, Cell metabolism.

[11]  K. Kiguchi,et al.  Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applications , 2009, Nature Protocols.

[12]  P. Allavena,et al.  Cellular and molecular pathways linking inflammation and cancer. , 2009, Immunobiology.

[13]  M. Baccarini,et al.  Raf-1 addiction in Ras-induced skin carcinogenesis. , 2009, Cancer cell.

[14]  Ming Yi,et al.  Seeking unique and common biological themes in multiple gene lists or datasets: pathway pattern extraction pipeline for pathway-level comparative analysis , 2009, BMC Bioinformatics.

[15]  C. Dinarello,et al.  Immunological and inflammatory functions of the interleukin-1 family. , 2009, Annual review of immunology.

[16]  M. Borrello,et al.  Inflammation and cancer: the oncogene-driven connection. , 2008, Cancer letters.

[17]  Gary Hardiman,et al.  Hepatocyte necrosis induced by oxidative stress and IL-1 alpha release mediate carcinogen-induced compensatory proliferation and liver tumorigenesis. , 2008, Cancer cell.

[18]  B. Schönfisch,et al.  Analysis of risk factors determining prognosis of cutaneous squamous-cell carcinoma: a prospective study. , 2008, The Lancet. Oncology.

[19]  Michael Karin,et al.  NF-kappaB and cancer-identifying targets and mechanisms. , 2008, Current opinion in genetics & development.

[20]  S. Akira,et al.  Demonstration of inflammation-induced cancer and cancer immunoediting during primary tumorigenesis , 2008, Proceedings of the National Academy of Sciences.

[21]  H. Dinh,et al.  Opposing activities of two novel members of the IL-1 ligand family regulate skin inflammation , 2007, The Journal of experimental medicine.

[22]  R. Strieter,et al.  Opposing roles of murine duffy antigen receptor for chemokine and murine CXC chemokine receptor-2 receptors in murine melanoma tumor growth. , 2007, Cancer research.

[23]  S. Ethier,et al.  Activation of a Nuclear Factor κB/Interleukin-1 Positive Feedback Loop by Amphiregulin in Human Breast Cancer Cells , 2007, Molecular Cancer Research.

[24]  S. Werner,et al.  The Inflammasome Mediates UVB-Induced Activation and Secretion of Interleukin-1β by Keratinocytes , 2007, Current Biology.

[25]  Suzanne Schubbert,et al.  Hyperactive Ras in developmental disorders and cancer , 2007, Nature Reviews Cancer.

[26]  S. Cook.  Faculty Opinions recommendation of Binding of ras to phosphoinositide 3-kinase p110alpha is required for ras-driven tumorigenesis in mice. , 2007 .

[27]  G. Stamp,et al.  Binding of Ras to Phosphoinositide 3-Kinase p110α Is Required for Ras- Driven Tumorigenesis in Mice , 2007, Cell.

[28]  W. A. Yeudall,et al.  Chemokines and squamous cancer of the head and neck: targets for therapeutic intervention? , 2007, Expert review of anticancer therapy.

[29]  C. Waes.  Nuclear Factor-κB in Development, Prevention, and Therapy of Cancer , 2007 .

[30]  Y. Carmi,et al.  The involvement of IL-1 in tumorigenesis, tumor invasiveness, metastasis and tumor-host interactions , 2006, Cancer and Metastasis Reviews.

[31]  S. Yuspa,et al.  CXCR2 ligands and G-CSF mediate PKCα-induced intraepidermal inflammation , 2006 .

[32]  R. Strieter,et al.  CXCL1 induced by prostaglandin E2 promotes angiogenesis in colorectal cancer , 2006, The Journal of experimental medicine.

[33]  W. A. Yeudall,et al.  Down-regulation of CXCL5 inhibits squamous carcinogenesis. , 2006, Cancer research.

[34]  J. Minna,et al.  High expression of ligands for chemokine receptor CXCR2 in alveolar epithelial neoplasia induced by oncogenic kras. , 2006, Cancer research.

[35]  M. Mueller.  Inflammation in epithelial skin tumours: old stories and new ideas. , 2006, European journal of cancer.

[36]  Paul A. Khavari,et al.  Modelling cancer in human skin tissue , 2006, Nature Reviews Cancer.

[37]  Stephen M Hewitt,et al.  The role of interleukin 1 in growth and metastasis of human cancer xenografts. , 2006, Clinical cancer research : an official journal of the American Association for Cancer Research.

[38]  Y. Bourbonnais,et al.  Proteins with whey-acidic-protein motifs and cancer. , 2006, The Lancet. Oncology.

[39]  Ming Yi,et al.  WholePathwayScope: a comprehensive pathway-based analysis tool for high-throughput data , 2006, BMC Bioinformatics.

[40]  R. Strieter,et al.  Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization and tumor growth. , 2005, The Journal of clinical investigation.

[41]  G. Stamp,et al.  RalGDS is required for tumor formation in a model of skin carcinogenesis. , 2005, Cancer cell.

[42]  S. Yuspa,et al.  Protein Kinase Cα-Mediated Chemotaxis of Neutrophils Requires NF-κB Activity but Is Independent of TNFα Signaling in Mouse Skin In Vivo1 , 2005, The Journal of Immunology.

[43]  N. Fusenig,et al.  Cooperative Autocrine and Paracrine Functions of Granulocyte Colony-Stimulating Factor and Granulocyte-Macrophage Colony-Stimulating Factor in the Progression of Skin Carcinoma Cells , 2004, Cancer Research.

[44]  James B. Mitchell,et al.  Erratum: Nuclear factor-κB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma (Cancer Research (September 2004) 64 (6511-6523) , 2004 .

[45]  James B. Mitchell,et al.  Nuclear Factor-κB is an Important Modulator of the Altered Gene Expression Profile and Malignant Phenotype in Squamous Cell Carcinoma , 2004, Cancer Research.

[46]  M. Vidal,et al.  A keratin K5Cre transgenic line appropriate for tissue‐specific or generalized cre‐mediated recombination , 2004, Genesis.

[47]  D. Bar-Sagi,et al.  Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. , 2004, Cancer cell.

[48]  M. Burdick,et al.  Depletion of CXCR2 Inhibits Tumor Growth and Angiogenesis in a Murine Model of Lung Cancer1 , 2004, The Journal of Immunology.

[49]  Smadar Cohen,et al.  A continuous delivery system of IL‐1 receptor antagonist reduces angiogenesis and inhibits tumor development , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[50]  C. Vinson,et al.  Activation of Cutaneous Protein Kinase Cα Induces Keratinocyte Apoptosis and Intraepidermal Inflammation by Independent Signaling Pathways , 2003, The Journal of Immunology.

[51]  Jennifer Y. Zhang,et al.  NF-κB blockade and oncogenic Ras trigger invasive human epidermal neoplasia , 2003, Nature.

[52]  Mark Coles,et al.  Transgenic mice with hematopoietic and lymphoid specific expression of Cre , 2003, European journal of immunology.

[53]  G. Merlino,et al.  Progress in cutaneous cancer research. , 2002, The journal of investigative dermatology. Symposium proceedings.

[54]  Kazuhiro Usui,et al.  Proinflammatory Cytokine IL-1β Promotes Tumor Growth of Lewis Lung Carcinoma by Induction of Angiogenic Factors: In Vivo Analysis of Tumor-Stromal Interaction1 , 2002, The Journal of Immunology.

[55]  A. Kraker,et al.  Src Family Kinases Phosphorylate Protein Kinase C δ on Tyrosine Residues and Modify the Neoplastic Phenotype of Skin Keratinocytes* , 2002, The Journal of Biological Chemistry.

[56]  R. Hasina,et al.  Paracrine angiogenic loop between head‐and‐neck squamous‐cell carcinomas and macrophages , 2001, International journal of cancer.

[57]  D. Hanahan,et al.  MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis , 2000, Cell.

[58]  G. Dong,et al.  Growth Regulated Oncogene-α expression by murine squamous cell carcinoma promotes tumor growth, metastasis, leukocyte infiltration and angiogenesis by a host CXC Receptor-2 dependent mechanism , 2000, Oncogene.

[59]  T. Magnuson,et al.  Targeted disruption of the epidermal growth factor receptor impairs growth of squamous papillomas expressing the v-ras(Ha) oncogene but does not block in vitro keratinocyte responses to oncogenic ras. , 1997, Cancer research.

[60]  A. Israël,et al.  I kappa B epsilon, a novel member of the IκB family, controls RelA and cRel NF‐κB activity , 1997 .

[61]  T. Magnuson,et al.  Activation of the Epidermal Growth Factor Receptor Signal Transduction Pathway Stimulates Tyrosine Phosphorylation of Protein Kinase C (*) , 1996, The Journal of Biological Chemistry.

[62]  K. Herrup,et al.  Targeted disruption of mouse EGF receptor: effect of genetic background on mutant phenotype. , 1995, Science.

[63]  I. Weinstein,et al.  Activated ras genes occur in human actinic keratoses, premalignant precursors to squamous cell carcinomas. , 1995, Archives of dermatology.

[64]  A. Dunn,et al.  Autocrine transforming growth factor alpha is dispensible for v-rasHa-induced epidermal neoplasia: potential involvement of alternate epidermal growth factor receptor ligands. , 1995, Cancer research.

[65]  N. Rice,et al.  The PEST-like sequence of I kappa B alpha is responsible for inhibition of DNA binding but not for cytoplasmic retention of c-Rel or RelA homodimers , 1995, Molecular and cellular biology.

[66]  S. Yuspa,et al.  Alterations in murine keratinocyte differentiation induced by activated rasHa genes are mediated by protein kinase C-alpha. , 1994, Cancer research.

[67]  J. Sundberg,et al.  Ornithine decarboxylase expression in cutaneous papillomas in SENCAR mice is associated with altered expression of keratins 1 and 10. , 1994, Cancer research.

[68]  N. Rice,et al.  In vivo control of NF‐kappa B activation by I kappa B alpha. , 1993, The EMBO journal.

[69]  S. Yuspa,et al.  Coordinate changes in gene expression which mark the spinous to granular cell transition in epidermis are regulated by protein kinase C , 1993, The Journal of cell biology.

[70]  D. Roop,et al.  Altered regulation of growth and expression of differentiation-associated keratins in benign mouse skin tumors. , 1991, Carcinogenesis.

[71]  D. Roop,et al.  Regulated expression of differentiation-associated keratins in cultured epidermal cells detected by monospecific antibodies to unique peptides of mouse epidermal keratins. , 1987, Differentiation; research in biological diversity.

[72]  T. Kupper,et al.  Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1 alpha and beta mRNA. Keratinocyte epidermal cell-derived thymocyte-activating factor is identical to interleukin 1 , 1986, The Journal of experimental medicine.

[73]  S. Yuspa,et al.  Inducible cutaneous inflammation reveals a protumorigenic role for keratinocyte CXCR2 in skin carcinogenesis. , 2009, Cancer research.

[74]  S. Yuspa,et al.  Isolation and short-term culture of primary keratinocytes, hair follicle populations and dermal cells from newborn mice and keratinocytes from adult mice for in vitro analysis and for grafting to immunodeficient mice , 2008, Nature Protocols.

[75]  C. Van Waes.  Nuclear factor-kappaB in development, prevention, and therapy of cancer. , 2007, Clinical cancer research : an official journal of the American Association for Cancer Research.

[76]  S. Ethier,et al.  Activation of a nuclear factor kappaB/interleukin-1 positive feedback loop by amphiregulin in human breast cancer cells. , 2007, Molecular cancer research : MCR.

[77]  S. Yuspa,et al.  CXCR2 ligands and G-CSF mediate PKCalpha-induced intraepidermal inflammation. , 2006, The Journal of clinical investigation.

[78]  James B. Mitchell,et al.  Nuclear factor-kappaB is an important modulator of the altered gene expression profile and malignant phenotype in squamous cell carcinoma. , 2004, Cancer research.

[79]  Jennifer Y. Zhang,et al.  NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. , 2003, Nature.

[80]  G. Kollias,et al.  Mice deficient in tumor necrosis factor-alpha are resistant to skin carcinogenesis. , 1999, Nature medicine.

[81]  A. Israël,et al.  I kappa B epsilon, a novel member of the I kappa B family, controls RelA and cRel NF-kappa B activity. , 1997, The EMBO journal.

[82]  S. Fischer,et al.  Modulation of interleukin‐1α mRNA expression in mouse epidermis by tumor promoters and antagonists , 1993 .

[83]  W. Pierceall,et al.  Ras gene mutation and amplification in human nonmelanoma skin cancers , 1991, Molecular carcinogenesis.

[84]  D. Roop,et al.  The v‐ras oncogene inhibits the expression of differentiation markers and facilitates expression of cytokeratins 8 and 18 in mouse keratinocytes , 1990, Molecular carcinogenesis.

[85]  D. Lowy,et al.  An activated Harvey ras oncogene produces benign tumours on mouse epidermal tissue , 1986, Nature.